Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 36: 1269-1281, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whicher, J. T.
Right arrow Articles by Evans, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whicher, J. T.
Right arrow Articles by Evans, S. W.

Clinical Chemistry, Vol 36, 1269-1281, Copyright © 1990 by American Association for Clinical Chemistry

Cytokines in disease

JT Whicher and SW Evans
Department of Chemical Pathology and Immunology, University of Leeds, Old Medical School, U.K.

Cytokines are peptides used by immune and inflammatory cells to communicate with each other and to control the milieu interieur in which they operate. Recent evidence suggests that they are of immense importance in controlling the local and systemic events of the immune response, inflammation, hemopoiesis, healing, and the systemic response to injury. Many of them can now be measured by immunoassay, and the role of such measurements in the diagnosis and management of disease is actively under investigation. Similarly, the availability of recombinant DNA techniques to produce cytokines in almost unlimited quantities is leading to new and exciting therapeutic applications.


The following articles in journals at HighWire Press have cited this article:


Home page
 MicrobiologyHome page
H. M. Linge, I. Sastalla, D. P. Nitsche-Schmitz, A. Egesten, and I.-M. Frick
Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect
Microbiology, November 1, 2007; 153(11): 3800 - 3808.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Bertsch, W. Zimmer, W. Casarin, C. Denz, M. Quintel, and K. Fassbender
Real-Time PCR Assay with Fluorescent Hybridization Probes for Rapid Interleukin-6 Promoter (-174G{->}C) Genotyping
Clin. Chem., October 1, 2001; 47(10): 1873 - 1874.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Yumoto, H. Nakae, K. Fujinaka, S. Ebisu, and T. Matsuo
Interleukin-6 (IL-6) and IL-8 Are Induced in Human Oral Epithelial Cells in Response to Exposure to Periodontopathic Eikenella corrodens
Infect. Immun., January 1, 1999; 67(1): 384 - 394.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Esser, W. Glienke, R. Andreesen, R. E. Unger, M. Kreutz, H. Rubsamen-Waigmann, and H. von Briesen
Individual Cell Analysis of the Cytokine Repertoire in Human Immunodeficiency Virus-1-Infected Monocytes/Macrophages by a Combination of Immunocytochemistry and In Situ Hybridization
Blood, June 15, 1998; 91(12): 4752 - 4760.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.